F

Fennec Pharmaceuticals
D

FENC

8.77000
USD
0.51
(6.23%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-19
حجم السوق
244,083,991
أصول ذات صلة الأخبار المقالات

العنوان: Fennec Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.